Bloomberg News
(3/25, Cortez) reported that Symplicity, "a Medtronic Inc. device used
to control hard-to-treat high blood pressure by burning overactive
nerves with a burst of radio-frequency energy, helped reduce the
condition," according to research presented at the American College of
Cardiology meeting. The study included more than 150 individuals with
drug- resistant hypertension. Researchers found that, "after six
months,
71 percent improved." Twenty-four "patients who were followed for three
years all recorded lower blood pressure after the procedure, which is
approved for sales abroad."
Dow Jones Newswire
(3/25) reported, "In a separate trial, 106 patients were randomized to
two groups: one group received renal denervation plus their previous
treatment of drugs while the other--the control group--continued to take
their regular drugs." Researchers reported that "the 47 patients
receiving the therapy sustained a significant drop in blood pressure at a
year compared to six months." The patients "receiving only
their regular drugs didn't see a significant reduction in blood pressure
at six months, at which point 35 patients who qualified for renal
denervation received it," and then proceeded, six months later, to
experience a similar reduction in blood pressure.
No comments:
Post a Comment